When was Bayou Biolabs founded?

Bayou Biolabs was founded in 1992.

Where is Bayou Biolabs located?

Bayou Biolabs is headquartered in Metairie, United States.

Is Bayou Biolabs a funded company?

Bayou Biolabs is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Bayou Biolabs rank among its competitors?

Bayou Biolabs ranks 2101st amongst 2827 active competitors, of which 515 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Bayou Biolabs?

Bayou Biolabs' top competitors include Abcam, Sutro Biopharma and Synthego. Among them, Antheia secured the most recent funding round in January, 2026.

Bayou Biolabs - 2026 Company Profile & Competitors

Bayou Biolabs is an unfunded company based in Metairie (United States), founded in 1992. It operates as a Provider of custom molecular biology reagents and services. Bayou Biolabs has not raised any funding yet. The company has 2827 active competitors, including 515 funded and 457 that have exited. Its top competitors include companies like Abcam, Sutro Biopharma and Synthego.

Company Details

Website: bayoubiolabs.com
Email ID: *****@bayoubiolabs.com
Phone Number: +1 **********

Key Metrics

Founded Year

1992

Location

Metairie, United States

Stage

Unfunded

Ranked

2101^st among 2827 active competitors

Similar Companies

Sutro Biopharma & 2960 more

View Bayou Biolabs' full profile

Bayou Biolabs has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bayou Biolabs include Abcam, Sutro Biopharma and Synthego. Here is the list of Top 10 competitors of Bayou Biolabs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	75/100
2nd	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
3rd	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
4th	Avidity Biosciences 2012, San Diego (United States), Acquired	RNA therapeutics innovator targeting muscle and other diseases with AOC platform	$143M	RTW Investments, Takeda Ventures & 20 others	70/100
5th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	67/100
6th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
7th	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	67/100
8th	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
9th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
10th	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
2101st	Bayou Biolabs 1992, Metairie (United States), Unfunded	Provider of custom molecular biology reagents and services	-	-	24/100